The predictive value of liver tests for the presence of liver metastases

© 2023 The Authors..

Aim: To analyze the predictive value of biochemical liver tests in patients with malignant melanoma, breast, colorectal or lung cancers at the time of diagnosis of liver metastases.

Methods: A retrospective review of patients with the above-mentioned solid tumors at MedStar Georgetown University Hospital from 2016-2020.

Results: The highest optimal cutoff according to sensitivity and specificity for the presence of liver metastases was for AST ≥1.5 × ULN for melanoma, lung, and breast cancers and ≥2 × ULN for colorectal cancer, ALT ≥1.25 × ULN for melanoma, breast and colorectal cancers and ≥1.5 × ULN for lung cancer, and ALP ≥1.5 × ULN for melanoma, breast and colorectal cancers.

Conclusion: Using thresholds of liver enzymes above the ULN may improve the diagnostic accuracy for the presence of liver metastases.

Medienart:

E-Artikel

Erscheinungsjahr:

2023

Erschienen:

2023

Enthalten in:

Zur Gesamtaufnahme - volume:10

Enthalten in:

Hepatic oncology - 10(2023), 3 vom: 23. Sept., Seite HEP48

Sprache:

Englisch

Beteiligte Personen:

Kimchy, Alexandra V [VerfasserIn]
Singh, Harjit [VerfasserIn]
Parikh, Esha [VerfasserIn]
Rosenberg, Jessica [VerfasserIn]
Sanghavi, Kavya [VerfasserIn]
Lewis, James H [VerfasserIn]

Links:

Volltext

Themen:

Breast neoplasms
Colonic neoplasms
Journal Article
Liver biochemical tests
Liver metastases
Lung neoplasms
Malignant melanoma

Anmerkungen:

Date Revised 28.10.2023

published: Electronic-eCollection

Citation Status PubMed-not-MEDLINE

doi:

10.2217/hep-2023-0003

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM363776761